טלזנה 0.25 מג ישראל - עברית - Ministry of Health

טלזנה 0.25 מג

pfizer pharmaceuticals israel ltd - talazoparib as tosylate - קפסולה קשיחה - talazoparib as tosylate 0.25 mg - talazoparib

טלזנה 1 מג ישראל - עברית - Ministry of Health

טלזנה 1 מג

pfizer pharmaceuticals israel ltd - talazoparib as tosylate - קפסולה קשיחה - talazoparib as tosylate 1 mg - talazoparib

ווטריינט 200 מג ישראל - עברית - Ministry of Health

ווטריינט 200 מג

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 200 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ווטריינט 400 מג ישראל - עברית - Ministry of Health

ווטריינט 400 מג

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 400 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ווטריינט 200 מ"ג ישראל - עברית - Ministry of Health

ווטריינט 200 מ"ג

glaxo smith kline (israel) ltd - pazopanib as hydrochloride 200 mg - film coated tablets - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ווטריינט 400 מ"ג ישראל - עברית - Ministry of Health

ווטריינט 400 מ"ג

glaxo smith kline (israel) ltd - pazopanib as hydrochloride 400 mg - film coated tablets - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

סלאזופירין אי.אנ. ישראל - עברית - Ministry of Health

סלאזופירין אי.אנ.

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - טבליות עם ציפוי אנטרי - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - for active rheumatoid arthritis which is not controlled by antiinflammatory drugs. ulcerative colitis, crohn's disease, pyoderma gangrenosum.

סלאזופירין ישראל - עברית - Ministry of Health

סלאזופירין

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - טבליה - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - treatment of ulcerative colitis and crohn's disease.

אקסיטיניב טבע  1 מג ישראל - עברית - Ministry of Health

אקסיטיניב טבע 1 מג

teva israel ltd - axitinib - טבליות מצופות פילם - axitinib 1 mg - axitinib

אקסיטיניב טבע  3 מג ישראל - עברית - Ministry of Health

אקסיטיניב טבע 3 מג

teva israel ltd - axitinib - טבליות מצופות פילם - axitinib 3 mg - axitinib